Search results
Results from the WOW.Com Content Network
Alcohol septal ablation (ASA) is a minimally invasive heart procedure to treat hypertrophic cardiomyopathy (HCM). [1]It is a percutaneous, minimally invasive procedure performed by an interventional cardiologist to relieve symptoms and improve functional status in eligible patients with severely symptomatic HCM who meet strict clinical, anatomic and physiologic selection criteria.
Septal myectomy is associated with a low perioperative mortality and a high late survival rate. A study at the Mayo Clinic found surgical myectomy performed to relieve outflow obstruction and severe symptoms in HCM was associated with long-term survival equivalent to that of the general population, and superior to obstructive HCM without operation.
When performed properly, an alcohol septal ablation induces a controlled heart attack, in which the portion of the interventricular septum that involves the left ventricular outflow tract is infarcted and will contract into a scar. There is debate over which people are best served by surgical myectomy, alcohol septal ablation, or medical therapy.
According to a recent study, baby teeth contain an abundance of stem cells, a very special type of cell that can potentially grow replacement tissue in the body and cure a number of diseases.
Ablysinol (a brand of 99% ethanol medical alcohol) was sold from $1,300 to $10,000 per 10-pack [Give volume amount please] in 2020 due to FDA administrator action granting exclusivity when used for treating hypertrophic obstructive cardiomyopathy with alcohol septal ablation in the US through 2025, despite "misuse" of the orphan drug act.
Alfred Blalock was an American surgeon most known for his work on the Blue Baby syndrome. [2] C. Rollins Hanlon was also an American surgeon but was best known for his work in cardiology. [3] The procedure that these two men created, known as the Blalock–Hanlon procedure, was a new concept termed atrial septectomy.
The Blalock–Thomas–Taussig shunt (BTT shunt), [1] previously known as the Blalock–Taussig Shunt (BT shunt), [2] is a surgical procedure used to increase blood flow to the lungs in some forms of congenital heart disease [3] such as pulmonary atresia and tetralogy of Fallot, which are common causes of blue baby syndrome. [3]
The procedure was developed to treat transposition of the great vessels, eponymously known as blue baby syndrome. This is a condition in which the aorta and pulmonary artery are attached to the heart in an opposite order from what is usually present at birth, resulting in the aorta being the outflow tract for the right ventricle and the ...